Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592709 · ClinicalTrials.gov registry record
Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry
A clinical trial of Brain Diseases, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 84
- Enrollment target
- 1
- Study location
NCT00592709 is a study of Brain Diseases that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 84 participants, below the 6,011-participant average among 12 other Brain Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00592709, a study of Brain Diseases, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
We are collecting brain tissue specimens and blood samples from patients at Vanderbilt University Medical Center who are undergoing intracranial surgery to remove brain tissue, including brain tumors, tissue from epilepsy surgery and brain tissue removed during surgery for other non-cancerous types of brain tissus. These specimens will then be studied using a novel microscopic laser-directed protein mass spectrometric analysis, looking for unique protein signatures.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center, Department of Neurological Surgery - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2003-05 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00592709
The ClinicalTrials.gov registry entry for NCT00592709 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,011-participant average among 12 other Brain Diseases trials with a reported enrollment target (99% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00592709 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00592709 about?
NCT00592709 is a clinical study titled "Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry". We are collecting brain tissue specimens and blood samples from patients at Vanderbilt University Medical Center who are undergoing intracranial surgery to remove brain tissue, including brain tumors, tissue from epilepsy surgery and brain tissue removed during surgery for other non-cancerous types ...
What is the current status of trial NCT00592709?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2003-05. Estimated completion is 2012-12.
What conditions does trial NCT00592709 study?
This clinical trial studies the following conditions: Brain Diseases.
Who is sponsoring clinical trial NCT00592709?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00592709 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RECRUITING · Phase 1
-
Amygdala Memory Enhancement
RECRUITING · NA
-
University of Central Florida CereBank
RECRUITING
-
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
RECRUITING · NA
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.